Filip Lhota

Prague, PR 17000, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Classification of germline variants identified in cancer predisposition genetic testing - consensus of the CZECANCA consortium.

Classification of germline variants identified in cancer predisposition genetic testing - consensus of the CZECANCA consortium.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: December 29, 2023

The Cause of Hereditary Hearing Loss in GJB2 Heterozygotes-A Comprehensive Study of the GJB2/DFNB1 Region.

The Cause of Hereditary Hearing Loss in GJB2 Heterozygotes-A Comprehensive Study of the GJB2/DFNB1 Region.

Journal: Genes

Published: March 23, 2021

Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer.

Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer.

Journal: Cancers

Published: March 15, 2020

Germline CHEK2 Gene Mutations in Hereditary Breast Cancer Predisposition - Mutation Types and their Biological and Clinical Relevance.

Germline CHEK2 Gene Mutations in Hereditary Breast Cancer Predisposition - Mutation Types and their Biological and Clinical Relevance.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: August 15, 2019

Contribution of Massive Parallel Sequencing to Diagnosis of Hereditary Ovarian Cancer in the Czech Republic.

Contribution of Massive Parallel Sequencing to Diagnosis of Hereditary Ovarian Cancer in the Czech Republic.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: August 15, 2019

Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer.

Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer.

Journal: International journal of cancer

Published: February 06, 2019

Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes.

Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes.

Journal: PloS one

Published: October 19, 2017

Multiplex PCR and NGS-based identification of mRNA splicing variants: Analysis of BRCA1 splicing pattern as a model.

Multiplex PCR and NGS-based identification of mRNA splicing variants: Analysis of BRCA1 splicing pattern as a model.

Journal: Gene

Published: June 28, 2017

RE: frameshift variant FANCL*c.1096_1099dupATTA is not associated with high breast cancer risk.

RE: frameshift variant FANCL*c.1096_1099dupATTA is not associated with high breast cancer risk.

Journal: Clinical genetics

Published: July 14, 2016

Identification and Functional Testing of ERCC2 Mutations in a Multi-national Cohort of Patients with Familial Breast- and Ovarian Cancer.

Identification and Functional Testing of ERCC2 Mutations in a Multi-national Cohort of Patients with Familial Breast- and Ovarian Cancer.

Journal: PLoS genetics

Published: June 08, 2016

The c.657del5 variant in the NBN gene predisposes to pancreatic cancer.

The c.657del5 variant in the NBN gene predisposes to pancreatic cancer.

Journal: Gene

Published: March 10, 2016

Hereditary truncating mutations of DNA repair and other genes in BRCA1/BRCA2/PALB2-negatively tested breast cancer patients.

Hereditary truncating mutations of DNA repair and other genes in BRCA1/BRCA2/PALB2-negatively tested breast cancer patients.

Journal: Clinical genetics

Published: December 12, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026